Photochemotherapy Market, Global Outlook and Forecast 2023-2028

Report ID: 1889486 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story

Photochemotherapy is a treatment that uses special drugs, sometimes called photosensitizing agents, along with light to kill cancer cells. The drugs only work after they have been activated or “turned on” by certain kinds of light. PDT may also be called photoradiation therapy, phototherapy, or photodynamic therapy(PDT).
This report contains market size and forecasts of Photochemotherapy in Global, including the following market information:
Global Photochemotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Photochemotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Porfimer Sodium (Photofrin) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Photochemotherapy include Mayo Clinic, Retina Group, Sanofi, Ambicare Health, DUSA Pharmaceuticals, Biolitec, Bausch Health, PhotoMedex and Beiersdorf, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Photochemotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Photochemotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Photochemotherapy Market Segment Percentages, by Type, 2021 (%)
Porfimer Sodium (Photofrin)
Aminolevulinic Acid (ALA or Levulan)
Visudyne
Others
Global Photochemotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Photochemotherapy Market Segment Percentages, by Application, 2021 (%)
Oncology
Ophthalmology
Dermatology
Others
Global Photochemotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Photochemotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Photochemotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Photochemotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mayo Clinic
Retina Group
Sanofi
Ambicare Health
DUSA Pharmaceuticals
Biolitec
Bausch Health
PhotoMedex
Beiersdorf
Lumenis
Soligenix
Biofrontera
Theralase Technologies
Galderma
Quest Pharmatech

Frequently Asked Questions
Photochemotherapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Photochemotherapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Photochemotherapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports